These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2478309)

  • 1. TFT and 6TG resistance of mouse lymphoma cells to analogs of azacytidine.
    McGregor DB; Brown AG; Cattanach P; Shepherd W; Riach C; Daston DS; Caspary WJ
    Carcinogenesis; 1989 Nov; 10(11):2003-8. PubMed ID: 2478309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mutagenicity of 5-azacytidine and other inhibitors of replicative DNA synthesis in the L5178Y mouse lymphoma cell.
    Amacher DE; Turner GN
    Mutat Res; 1987 Jan; 176(1):123-31. PubMed ID: 2432424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular differentiation, cytidine analogs and DNA methylation.
    Jones PA; Taylor SM
    Cell; 1980 May; 20(1):85-93. PubMed ID: 6156004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do trifluorothymidine-resistant mutants of L5178Y mouse lymphoma cells re-express thymidine kinase activity following 5-azacytidine treatment?
    Moore MM; Applegate ML; Hozier JC
    Mutat Res; 1988 Feb; 207(2):77-82. PubMed ID: 2448615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micronuclei induced by modulators of methylation: analogs of 5-azacytidine.
    Stopper H; Körber C; Gibis P; Spencer DL; Caspary WJ
    Carcinogenesis; 1995 Jul; 16(7):1647-50. PubMed ID: 7542178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in situ protocol for measuring the expression of chemically-induced mutations in mammalian cells.
    Spencer DL; Hines KC; Caspary WJ
    Mutat Res; 1994 Apr; 312(2):85-97. PubMed ID: 7510835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utilization of trifluorothymidine (TFT) to select for thymidine kinase-deficient (TK-/-) mutants from L5178Y/TK+/- mouse lymphoma cells.
    Moore-Brown MM; Clive D; Howard BE; Batson AG; Johnson KO
    Mutat Res; 1981 Oct; 85(5):363-78. PubMed ID: 6795499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of mutagenicity and clastogenicity of 5-azacytidine in human lymphoblasts and Salmonella typhimurium.
    Call KM; Jensen JC; Liber HL; Thilly WG
    Mutat Res; 1986 May; 160(3):249-57. PubMed ID: 2421158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenicity of 5-azacytidine and related nucleosides in C3H/10T 1/2 clone 8 and V79 cells.
    Landolph JR; Jones PA
    Cancer Res; 1982 Mar; 42(3):817-23. PubMed ID: 6174215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the antileukemic activity of 5-AZA-2'-deoxycytidine, 1-beta-D-arabinofuranosylcytosine and 5-azacytidine against L1210 leukemia.
    Momparler RL; Momparler LF; Samson J
    Leuk Res; 1984; 8(6):1043-9. PubMed ID: 6083417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of tk-/- mutants of L5178Y mouse lymphoma cells in Fischer's medium.
    Clive D; Krehl R
    Mutat Res; 1991 Aug; 260(4):409-13. PubMed ID: 1908056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug resistance to 5-aza-2'-deoxycytidine, 2',2'-difluorodeoxycytidine, and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA into murine cells.
    Eliopoulos N; Cournoyer D; Momparler RL
    Cancer Chemother Pharmacol; 1998; 42(5):373-8. PubMed ID: 9771951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mouse lymphoma assay.
    Lloyd M; Kidd D
    Methods Mol Biol; 2012; 817():35-54. PubMed ID: 22147567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular phosphorylation of 1-beta-D-arabinofuranosylcytosine 5-azacytidine with intact fibrosarcoma and leukemic cells.
    Lee T; Karon M; Monparler RL
    Cancer Res; 1975 Sep; 35(9):2506-10. PubMed ID: 50132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The critical influence of temperature upon trifluorothymidine resistance in mouse lymphoma L5178Y/TK 3.7.2C cells.
    Amacher DE; Turner GN
    Mutat Res; 1989 Dec; 224(4):415-26. PubMed ID: 2479834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of mutations in mouse lymphoma L5178Y cells by ethylmethanesulphonate, benzidine and benzo[a]pyrene.
    Henderson L; Ransome S; Brabbs C; Tinner A; Davies S
    Mutagenesis; 1990; 5 Suppl():27-34. PubMed ID: 2184317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 5-azacytidine and congeners on DNA methylation and expression of deoxycytidine kinase in the human lymphoid cell lines CCRF/CEM/0 and CCRF/CEM/dCk-1.
    Antonsson BE; Avramis VI; Nyce J; Holcenberg JS
    Cancer Res; 1987 Jul; 47(14):3672-8. PubMed ID: 2439195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 5-azacytidine on DNA methylation and the malignant properties of B16 melanoma cells.
    Trainer DL; Kline T; Mallon F; Greig R; Poste G
    Cancer Res; 1985 Dec; 45(12 Pt 1):6124-30. PubMed ID: 2415238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of deoxycytidine kinase by 5-azacytidine in an HL-60 cell line resistant to arabinosylcytosine.
    Kong XB; Tong WP; Chou TC
    Mol Pharmacol; 1991 Feb; 39(2):250-7. PubMed ID: 1705001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Azacytidine inhibits the induction of transient TK-deficient cells by 5-bromodeoxyuridine. A novel hypothesis for the facilitation of hypermethylation by 5-bromodeoxyuridine.
    Call KM; Thilly WG
    Mutat Res; 1991 May; 248(1):101-14. PubMed ID: 1709444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.